Gideon developed the core technology behind Enzymit’s design platform and leads the company’s technological development and corporate strategy. His expertise lies in developing advanced computational algorithms to design and create novel antibodies and enzymes with superior accuracy and activity. Gideon received a Master of Science in Biochemistry and Molecular Dynamics from Tel Aviv University and a PhD in Computational Biology from the Weizmann Institute of Science.

Dror is a synthetic biology and protein engineering expert and co-developer of Enzymit’s core technology. With more than a decade of experience in biotech entrepreneurship and business operations, he brings extensive knowledge in multidisciplinary scientific techniques, including antibody and protein engineering, molecular biology, NGS, high throughput screenings, and biochemistry. Prior to co-founding Enzymit, he served as Innovation Project Manager at Biolojic Design. Prior to that, he was a founding scientist at IgC Bio, a computational antibody design startup. Dror received a Master of Science in Computational Protein Design from the Weizmann Institute of Science and a Bachelor’s Degree in Biology from Ben Gurion University of the Negev.

Markus Klinger is a specialist in biotech-enabled specialty ingredients, with some 15 years of experience in product development, strategy, and management. Prior to joining Enzymit, he held key leadership positions at Novozymes, including Head of Strategy and Ventures for Alternative Proteins, where he focused on driving business strategy, leading cross-functional teams and forging strategic partnerships. Prior to that, he was a Group Manager and Six Sigma Black Belt at DuPont managing front-end transformational innovation projects. Markus is completing an MBD from Copenhagen Business School and holds a PhD in Chemistry from Aarhus University.

Lior is a machine learning expert with an extensive background in computational biology. Prior to joining Enzymit, he served as the principal computational biology scientist in IgC Bio, a venture-backed computational antibody design company, and as Director of AI and Data Science at Anthem Inc. (now Elevance Health), where he led the Anthem Israel Innovation Center’s clinical informatics research team. Prior to that, he held a number of research positions at companies including NovellusDX (now Fore Bio) and IBM. Lior holds a BSc and a Master of Science in Computer Science and Computational Biology, both from the Hebrew University of Jerusalem.

Itay is a seasoned researcher and scientific leader with over 16 years of experience conducting and managing scientific programs. He has a strong background in molecular biology, biochemistry, and antibody and protein engineering. Prior to joining Enzymit, Itay worked as a research scientist for several biotech startups. Most recently, he served as Senior Scientific Director and Head of Innovation at Biolojic Design, where his responsibilities included funding, strategic planning, and project oversight. Itay received a PhD in Molecular Microbiology and Biochemistry from Tel Aviv University and completed a postdoctoral fellowship at Samuel Miller’s lab at the University of Washington in Seattle, researching bacterial photogensis.

Veronica is a biochemist with extensive experience in lab work, research and lab management. With an MSc in Biochemistry from the National University of Cordoba and a wealth of industry knowledge